Jan Galle

Summary

Country: Germany

Publications

  1. ncbi [Therapy of inflammatory kidney diseases. More than steroids?]
    J Galle
    Abteilung für Nephrologie, Medizinische Klinik, Universitatsklinikum Wurzburg
    Internist (Berl) 45:1388-94. 2004
  2. ncbi Impact of oxidized low density lipoprotein on vascular cells
    Jan Galle
    Department of Medicine, Division of Nephrology, Julius Maximilians University, Wurzburg, Germany
    Atherosclerosis 185:219-26. 2006
  3. ncbi Inflammation in uremic patients: what is the link?
    Jan Galle
    Department of Medicine, Division of Nephrology, University of Wurzburg, Wurzburg, Germany
    Kidney Blood Press Res 26:65-75. 2003
  4. ncbi Has the time come to use antioxidant therapy in uraemic patients?
    Jan Galle
    Medizinische Klinik, Schwerpunkt Nephrologie, , Germany
    Nephrol Dial Transplant 18:1452-5. 2003
  5. ncbi [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease]
    Jan Galle
    Medizinische Klinik der Universität Würzburg, Wurzburg, Germany
    Herz 29:4-11. 2004
  6. ncbi Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress
    J Galle
    Division of Nephrology, Department of Medicine, University Hospital of Wurzburg, Wurzburg, Germany
    Kidney Int Suppl 78:S120-3. 2001
  7. ncbi Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation
    J Galle
    Department of Medicine, Division of Nephrology, University Hospital of Wurzburg, Germany
    Miner Electrolyte Metab 25:263-8. 1999
  8. ncbi Atherogenic lipoproteins, oxidative stress, and cell death
    J Galle
    Department of Medicine, University Hospital of Wurzburg, Germany
    Kidney Int Suppl 71:S62-5. 1999
  9. ncbi Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress
    J Galle
    Department of Medicine, University Hospital of Wurzburg, Germany
    Kidney Int 55:1450-61. 1999
  10. ncbi Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA
    Jan Galle
    Department of Medicine, Julius Maximilians Universitat, Wurzburg, Germany
    J Am Soc Nephrol 14:1471-9. 2003

Collaborators

Detail Information

Publications33

  1. ncbi [Therapy of inflammatory kidney diseases. More than steroids?]
    J Galle
    Abteilung für Nephrologie, Medizinische Klinik, Universitatsklinikum Wurzburg
    Internist (Berl) 45:1388-94. 2004
    ..The clinical course and pathology of inflammatory kidney diseases have been reviewed extensively in this journal in 1997 and 2002...
  2. ncbi Impact of oxidized low density lipoprotein on vascular cells
    Jan Galle
    Department of Medicine, Division of Nephrology, Julius Maximilians University, Wurzburg, Germany
    Atherosclerosis 185:219-26. 2006
    ..Thus, through a variety of mechanisms, OxLDL importantly contributes to vascular dysfunction and remodeling...
  3. ncbi Inflammation in uremic patients: what is the link?
    Jan Galle
    Department of Medicine, Division of Nephrology, University of Wurzburg, Wurzburg, Germany
    Kidney Blood Press Res 26:65-75. 2003
    ..Based on pathophysiological considerations valid for uremic patients, we discuss therapeutical options that might help to reduce cardiovascular disease in uremic patients...
  4. ncbi Has the time come to use antioxidant therapy in uraemic patients?
    Jan Galle
    Medizinische Klinik, Schwerpunkt Nephrologie, , Germany
    Nephrol Dial Transplant 18:1452-5. 2003
  5. ncbi [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease]
    Jan Galle
    Medizinische Klinik der Universität Würzburg, Wurzburg, Germany
    Herz 29:4-11. 2004
    ....
  6. ncbi Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress
    J Galle
    Division of Nephrology, Department of Medicine, University Hospital of Wurzburg, Wurzburg, Germany
    Kidney Int Suppl 78:S120-3. 2001
    ..Both effects are mediated by O2- formation, with NADPH oxidase being a major source for O2-. Thus, OxLDL contributes importantly to vascular cellular turnover through the induction of oxidative stress...
  7. ncbi Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation
    J Galle
    Department of Medicine, Division of Nephrology, University Hospital of Wurzburg, Germany
    Miner Electrolyte Metab 25:263-8. 1999
    ..Methods to analyze lipoprotein modification are introduced, and functional consequences related to vascular and renal function are presented...
  8. ncbi Atherogenic lipoproteins, oxidative stress, and cell death
    J Galle
    Department of Medicine, University Hospital of Wurzburg, Germany
    Kidney Int Suppl 71:S62-5. 1999
    ..We therefore determined the impact of oxLDL and oxLp(a) on O2- formation and on necrotic and apoptotic cell death in vascular and glomerular cells...
  9. ncbi Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress
    J Galle
    Department of Medicine, University Hospital of Wurzburg, Germany
    Kidney Int 55:1450-61. 1999
    ..We assessed the effects of native (nLDL) and oxidized (oxLDL) low-density lipoprotein (LDL) and lipoprotein (a) [Lp(a)] on O2- formation and cell death in cultured human umbilical vein endothelial cells (HUVECs) and rabbit aorta (RA)...
  10. ncbi Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA
    Jan Galle
    Department of Medicine, Julius Maximilians Universitat, Wurzburg, Germany
    J Am Soc Nephrol 14:1471-9. 2003
    ..Lysophosphatidylcholine mimics the OxLDL effect, consistent with a causal role of this OxLDL compound. Stimulation of RhoA by OxLDL may contribute to vasospasm in atherosclerotic arteries...
  11. ncbi L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats
    Ulrike Raff
    Division of Nephrology, Department of Medicine, Julius Maximilian University, , Germany
    Nephron Physiol 101:p39-50. 2005
    ..Thus, different mechanisms have to be considered, in particular improved intrarenal hemodynamics...
  12. ncbi Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells
    Susanne B Schwedler
    Department of Medicine I, University of Wurzburg, Wurzburg, Germany
    Clin Chem 55:1728-31. 2009
    ..Here, we tested the impact of mCRP and nCRP on the uptake of acetylated LDL (acLDL), which is internalized by receptors similar to those of oxLDL in human endothelial cells...
  13. ncbi Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA
    Stefan Seibold
    Department of Medicine, University Hospital Wurzburg, Joseph Schneider Strasse 2, D 97080 Wurzburg, Germany
    J Am Soc Nephrol 15:3026-34. 2004
    ..OxLDL may importantly contribute to vascular hyperplasia in atherosclerosis and other diseases associated with increased levels of OxLDL...
  14. ncbi L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats
    Reinhard Schneider
    Division of Nephrology, Department of Medicine, Julius-Maximilians-University, , Germany
    Kidney Int 64:216-25. 2003
    ..l-Arg supplementation reduces O2- generation and significantly improves the expression of nitric oxide signaling proteins as well as the recovery phase of ischemic ARF...
  15. ncbi Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress
    Thomas E Hansen-Hagge
    Department of Medicine, Division of Nephrology, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Atherosclerosis 197:602-11. 2008
    ..The novel data may help to design adequate therapeutic strategies against oxLDL-induced cardiovascular diseases...
  16. ncbi Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy
    Jan Galle
    Department of Internal Medicine, University Hospital, Wurzburg, Germany
    Nephrol Dial Transplant 23:3174-83. 2008
    ..Experimental evidence demonstrates that angiotensin receptor blockers (ARBs) possess anti-inflammatory potential, which might contribute to reducing proteinuria and providing renoprotection...
  17. ncbi C-reactive protein: a family of proteins to regulate cardiovascular function
    Susanne B Schwedler
    Division of Nephrology, Department of Medicine, University of Wurzburg, Germany
    Am J Kidney Dis 47:212-22. 2006
    ....
  18. ncbi Down-regulation of MTUS1 in human colon tumors
    Christina Zuern
    Department of Medicine, Division of Nephrology, University Clinic of Wuerzburg, Wuerzburg, Germany
    Oncol Rep 23:183-9. 2010
    ..Since reduced expression of MTUS1 results in increased cellular proliferation, these data suggest that MTUS1 could be involved in the loss of proliferative control in human colon cancer...
  19. ncbi Identification of a new tumor suppressor gene located at chromosome 8p21.3-22
    Stefan Seibold
    Department of Internal Medicine I, Cologne General Hospital, Merheim Medical Center, Medical Faculty University of Cologne, Cologne, Germany
    FASEB J 17:1180-2. 2003
    ..In conclusion, we identified a tumor suppressor gene at chromosome 8p21.3-22, encoding a mitochondrial protein, controlling cellular proliferation...
  20. ncbi Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress
    J Galle
    Department of Medicine, University Hospital of Wurzburg, Germany
    Atherosclerosis 138:65-77. 1998
    ..This mechanism may play an important role in diabetic patients and may contribute to disturbed organ perfusion...
  21. ncbi Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice
    Susanne B Schwedler
    Division of Nephrology, Department of Medicine, University of Wurzburg, Wurzburg, Germany
    Circulation 112:1016-23. 2005
    ..We tested the hypothesis that the configuration of CRP (pentameric, or native [nCRP], versus monomeric, or modified [mCRP]) determines these different characteristics in an in vivo model...
  22. ncbi Oxidized LDL increases the sensitivity of the contractile apparatus in isolated resistance arteries for Ca(2+) via a rho- and rho kinase-dependent mechanism
    S S Bolz
    Physiologisches Institut, Ludwig Maximilians Universitat, Munchen, Department of Medicine, Division of Nephrology, University Hospital of Wurzburg, Wurzburg, Germany
    Circulation 102:2402-10. 2000
    ..CONCLUSIONS: OxLDL reduces VSM responsiveness to vasodilators by increasing VSM Ca(2+) but preferentially by sensitizing VSM to Ca(2+) via a Rho- and Rho kinase-dependent pathway...
  23. ncbi Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice
    Thomas Quaschning
    Department of Medicine, Division of Nephrology, , , Germany
    Nephrol Dial Transplant 18:479-83. 2003
    ..Thus, in the presence of an activated ET system, up-regulation of NO production may be capable of maintaining vascular tone in a normal range and therefore may prevent the development of hypertension...
  24. ncbi Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation
    Alexandra Heinloth
    Department of Medicine, Division of Nephrology, , Joseph-Schneider-Strasse 2, , Germany
    Atherosclerosis 162:93-101. 2002
    ..NO attenuates OxLDL-induced cytochrome c release and p53 accumulation via activation of sGC and cGMP formation. These effects may be of particular importance in arterial tissue with reduced NO activity...
  25. ncbi Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species
    Susanne B Schwedler
    Department of Medicine I, University Hospital Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Atherosclerosis 195:e76-84. 2007
    ..We evaluated the effects of two conformers of CRP (pentameric, or native [nCRP], versus monomeric, or modified [mCRP]) on vessel function and production of reactive oxygen species (ROS) in an in-vivo model of atherosclerosis...
  26. ncbi Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1
    Henning Morawietz
    Institute of Pathophysiology, Faculty of Medicine, Martin Luther University Halle Wittenberg, D 06097 Halle, Germany
    Clin Sci (Lond) 103:9S-12S. 2002
    ..This mechanism could promote the development and progression of endothelial dysfunction and atherosclerosis. In addition, endothelin receptor blockade could be considered as a new anti-atherosclerotic therapeutic principle...
  27. ncbi Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha
    Ingrid Fleming
    Institut für Kardiovaskuläre Physiologie, Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Cardiovasc Res 65:897-906. 2005
    ..We assessed whether the uncoupling of eNOS was associated with alterations in eNOS phosphorylation and/or the assembly of the eNOS signaling complex...
  28. ncbi Reduction of proteinuria with angiotensin receptor blockers
    Jan Galle
    Department of Nephrology and Dialysis at Klinikum Lüdenscheid, Ludenscheid, Germany
    Nat Clin Pract Cardiovasc Med 5:S36-43. 2008
    ..These data support the proposition that blockade of the renin-angiotensin system beyond that required for maximum blood pressure reduction provides optimum renal protection...
  29. ncbi Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling
    César Ibarra-Alvarado
    Rudolf Buchheim Institute for Pharmacology, Justus Liebig University, Giessen, Germany
    Mol Pharmacol 61:312-9. 2002
    ..These data suggest that vascular P(Ser239)-VASP is primarily regulated by the NO/cGMP pathway and may thus serve as a biochemical marker for the activity state of this essential pathway in endothelial function...
  30. ncbi Lack of iNOS impairs endothelial function in endothelin-1 transgenic mice
    Thomas Quaschning
    Department of Nephrology, University Hospital of Freiburg, Freiburg, Germany
    Kidney Blood Press Res 31:127-34. 2008
    ....
  31. ncbi Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading
    Thomas Quaschning
    Department of Nephrology, , Germany
    J Hypertens 23:979-85. 2005
    ..This indicates that, in this model, salt-induced hypertension is not mediated by endothelial dysfunction...
  32. ncbi Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension
    Thomas Quaschning
    Department of Nephrology, University Hospital of Freiburg, Freiburg, Germany
    Kidney Blood Press Res 29:351-9. 2006
    ..The present study investigated the effect of the vasopeptidase inhibitor AVE7688 in comparison to the ACE inhibitor ramipril on systolic blood pressure (SBP) and endothelial function in renovascular hypertension...
  33. ncbi Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice
    Thomas Quaschning
    Department of Nephrology, University Hospital of Freiburg, Freiburg, Germany
    J Am Soc Nephrol 18:730-40. 2007
    ..The human ET+/+ eNOS-/- mice therefore represent a novel model of hypertension as a result of an imbalance between the vascular ET-1 and NO systems...